LOS ANGELES, July 28, 2016 /FOR IMMEDIATE RELEASE/-MDgenesis LLC announced today it has recently signed a medical distribution agreement with Restor Physical Therapy Inc., a privately held physical therapy and rehabilitation corporation located in Southern California.
Restor Physical Therapy operates three busy clinics located in Orange County, California. Their main offices are located across from Hoag Hospital in Newport Beach with additional locations in Irvine and Fountain Valley.
“As physical therapists, much of our time is spent trying to build strength in patients” says John Horsley PT, president/owner of Restor Physical Therapy. “If a patient is not getting enough of the proper nutrients, including essential amino acids necessary for building new tissue, our attempts to build strength will be futile.”
“The MEND product line was designed specifically to repair tissue post-surgery and to address age-related muscle loss which we have already found helps us to get our patients the results their physicians desire” states Horsley. ‘My staff and I are very excited about the launch of this program due to the results our patients have already experienced clinically in our initial test group.”
MDgenesis LLC, a supplier of integrative medical products and physician training, was founded to specifically fulfill the growing need of practitioners who are interested in providing an integrative approach to patient care and provide them with the targeted, clinically proven, medical nutrition products recommended by today's leaders in integrative medicine.
“We are excited to partner with the team at Restor Physical Therapy” says Ken Roycroft, CEO of MDgenesis LLC. “their progressive approach at therapy and the entire teams’ commitment to attaining improved patient outcomes makes them a natural fit for company.”
AUSTIN, June 8, 2015 / PRNewswire - iReach / -- Neogenis Labs, Inc today announces that Neo40 Professional, a patented and clinically proven nitric oxide technology to support healthy circulation, will begin distribution with MDgenesis LLC, a supplier of integrative medical products to Orthopedic Surgeons. As a part of the agreement, Neo40 Professional will be incorporated into the pre and post-surgery and tissue repair protocols on their patient portal MDgenesis.com. MDgenesis will also be introducing Neo40 Professional to 300+ orthopedic surgeons throughout the Western states region and within the state of California.
Neo40 Professional was selected by MDgenesis LLC after reviewing numerous nitric oxide products available on the market. Nitric oxide or NO is one of the most important molecules produced in the human body and it is critically important for wound healing and tissue repair. "We considered developing our own nitric oxide product like many other companies do, but we quickly realized Neogenis patented technology is the only technology in the world that generates authentic NO gas when taken and we knew we could not compete with that” says Ken Roycroft, chief executive officer of the company. "nitric oxide signals stem cell mobilization and is the signal that allows for wound healing and regenerative medicine. We are very pleased to incorporate Neo40 Professional into our overall surgery program for our physicians and their patients."
Building from Nobel prize-winning nitric oxide research studies, Dr. Nathan Bryan of the UT Health Science Center developed a breakthrough, N-O producing supplement. From this foundation, Neogenis Labs, has developed a platform of solutions tailored for both the home nutrition and pharmaceutical markets. The orally disintegrating lozenge, Neo40 is unique, innovative, safe and very efficacious. Proven through numerous clinical studies, the Neogenis team is now poised to deliver key innovations to the healthcare industry, providing relief to millions suffering from N-O deficiency.
"Establishment of a distribution agreement with MDgenesis is a key step in our efforts to educate both physicians and patients on the importance of nitric oxide in health and regenerative medicine," says co-founder and Chief Science Officer Nathan S. Bryan, Ph.D., "the Physicians and Surgeons have seen the overwhelmingly positive feedback and response from patients and beginning to understand that patients see the impact of nitric oxide as a critical part of their recovery program.”
Neogenis Medical is the world leader in nitric oxide science with over 15 years of research, 4 issued patents and 5 published clinical trials. Neo40® Professional is clinically shown to increase N-O levels, which is essential for proper endothelial function and cardiovascular health.
Neogenis has been named to the 2015 Austin A-List by the Austin Chamber of Commerce through its Innovate Austin initiative and South by Southwest Interactive. The A-List companies, selected by a panel of independent judges from more than 275 nominations, were officially revealed and named to the annual Austin A-List of Hottest Startups.